Ocera Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 28   

Articles published

OCRX 5.42 -0.09 (-1.63%)
price chart
Ocera Therapeutics Inc.: Ocera Therapeutics Raises $25.2 Million in Public ...
PALO ALTO, Calif., July 10, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX) ("Ocera") today announced that it has priced an underwritten public offering of 4,200,000 shares of its common stock at an offering price of $6.00 per share.
Related articles »  
Ocera Therapeutics Announces Proposed Public Offering of Common Stock
PALO ALTO, Calif., July 9, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX) ("Ocera" or "the Company") today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten ...
Related articles »  
Ocera Therapeutics CEO Buys $59300 in Stock (OCRX)
Ocera Therapeutics logo Ocera Therapeutics (NASDAQ:OCRX) CEO Linda S. Grais acquired 10,000 shares of the company's stock on the open market in a transaction dated Friday, July 11th. The stock was purchased at an average price of $5.93 per share, ...
Ocera Therapeutics CEO Linda S. Grais Acquires 10000 Shares (OCRX)  Watch List News (press release)
Related articles »  
Biotech New Lows: VIVUS (NASDAQ:VVUS), Ocera Therapeutics Inc. (NASDAQ ...
In connection with the attendance of the VIVUS, Inc.(NASDAQ:VVUS) at the 2014 Wells Fargo Healthcare Conference, the Company distributed and presented the slide attached hereto as Exhibit 99.1 as part of the Presentation that was filed as Exhibit 99.1 ...
Ocera Therapeutics CEO Purchases $59300 in Stock (OCRX)
Shares of Ocera Therapeutics (NASDAQ:OCRX) traded down 0.85% on Tuesday, hitting $5.85. 62,256 shares of the company's stock traded hands. Ocera Therapeutics has a 52-week low of $2.00 and a 52-week high of $19.94. The stock has a 50-day ...
Unusual Volume at Healthcare: Biodel Inc. (NASDAQ:BIOD), Ocera Therapeutics ...
On May 19, 2014, Gerard Michel, the Chief Financial Officer of Biodel Inc. (NASDAQ;BIOD), provided notice of his intention to resign from the Company effective May 30, 2014 to pursue a new career opportunity. The Company is in the process of commencing ...
Volatility Measure: Ocera Therapeutics (NASDAQ:OCRX), Novartis (NYSE:NVS ...
Ocera Therapeutics Inc (NASDAQ:OCRX) [Trend Analysis] reported that it has priced an underwritten public proposing of 4.20M shares of its common stock at an offering price of $6.00 per share.
Top Losers: Potbelly (NASDAQ:PBPB), Net Element International (NASDAQ ...  Tech News
Related articles »  
Stocks under bearish claws � Ocera Therapeutics (NASDAQ:OCRX), Quest Rare ...
Ocera Therapeutics Inc (NASDAQ:OCRX) ended its recent business day with the tumbled of 16.55% and closed at the price of $5.95 after opening at $6.00.
Related articles »  
Healthcare Decliners: Organovo Holdings Inc. (NYSEMKT:ONVO), Spectrum ...
Ocera Therapeutics (NASDAQ:OCRX) announced that it has priced an underwritten public offering of 4,200,000 shares of its common stock at an offering price of $6.00 per share.
Biotech losers: Imprimis Pharmaceuticals Inc (NASDAQ:IMMY), Vital Therapies ...  Markets Insider
Related articles »  
Biotech Unusual Volume: Ibio Inc (NYSEMKT:IBIO), Ultragenyx Pharmaceutical ...
Ocera has also granted the underwriters a 30-day option to purchase up to an additional 630,000 shares of common stock, which would result in additional gross proceeds of $3.78 million, if exercised in full.